Kevin HernSell
Novartis AG Common Stock · Transaction Aug 27, 2026 · Filed Sep 25, 2026 · $15,001 to $50,000
SWISS EXCHANGE · NVS
-0.12% · -$0.1700 · Vol 1.5M
Market closed · last close 4:00 PM ET · price as of 19:00:00 ET
Novartis AG
Pharmaceuticals
$143.11
Follow $NVS
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $NVS by emailVeridion Score
Refresh
Score snapshot refresh in progress
Veridion Score History · 90D
Score not reportedVeridion does not publish a score-history trend for NVS until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
AI Analysis
SovereignWhy is NVS moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Novartis AG
PharmaceuticalsListed since
1996
Employees
75K
Country
CH
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$142.77
Day high
$143.29
Day low
$140.68
Previous close
$143.28
52W high
$168.62
-15.13% from high
52W low
$121.80
46% of range
Market cap
$272.3B
P/E
20.66×
EPS
$6.62
Beta
0.03
Shares out
1.9B
Volume
1.5M
0.65× rel vol
Avg volume
2.4M
VWAP
$142.12
Price history computed in-house
1W
+1.50%
1M
+4.10%
3M
-7.10%
1Y
+9.19%
YTD
+3.80%
SMA 50 $149.29 · below
SMA 200 $150.87 · below
52W position 46%
NVS overview
Related filings and maps
Public disclosures
Congress activity in NVS
21 filers · 55 buys · 42 sells (2 labeled S (partial)) · Jun 12, 2014 to Aug 27, 2026 · House 85 / Senate 12
All available history · Latest 5 of 97 lines · Read 2026-10-09T02:57:17.676Z
Official filing ↗
Novartis AG Common Stock · Transaction Mar 31, 2026 · Filed Jul 21, 2026 · $1,001 to $15,000
Novartis AG Common Stock · Transaction Mar 30, 2026 · Filed Jul 21, 2026 · $15,001 to $50,000
Novartis AG Common Stock · Transaction Oct 31, 2025 · Filed Nov 21, 2025 · $1,001 to $15,000
Novartis AG Common Stock · Transaction Oct 30, 2025 · Filed Nov 21, 2025 · $1,001 to $15,000
Federal contracts
NVS contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for NVS in this window.
Lobbying spend
NVS lobbying filings, year to date.
Registered lobbying filings matched to Novartis AG.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for NVS in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for NVS.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.